# DIAGAST – FDA Inspection, Feb 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/diagast/2956b5db-20d5-4502-9e06-ef04d8783a89
Source feed: FDA_Inspections

> FDA inspection 1012901 of DIAGAST, February 21, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1012901
- Company Name: DIAGAST
- Inspection Date: 2017-02-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1236304 - 2024-04-19](https://www.keypedia.com/records/fda_inspections/diagast/d15ba283-2382-4e2b-ba78-de05c6b00630)
- [FDA Inspection 1087957 - 2019-03-21](https://www.keypedia.com/records/fda_inspections/diagast/2d8b54ee-8267-42cd-aac2-afaf3edaeee8)
- FDA Inspection 927715 - 2015-03-17
- FDA Inspection 715544 - 2011-03-08
- FDA Inspection 594229 - 2009-01-16

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/prabhu-p-raju/2c0aaede-fe16-4431-bc21-614d7f18cb32)

Company: https://www.keypedia.com/companies/diagast/c0e0edce-1abe-473a-9127-8abb20d191a6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
